Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

Item

http://www.wikidata.org/entity/Q36033068

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@ast

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@en

type

Item

label

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@ast

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@en

prefLabel

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@ast

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@en

P1476

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy

@en

P2093

Itzhak Avital

http://www.w3.org/2001/XMLSchema#string

Jeremy L Davis

http://www.w3.org/2001/XMLSchema#string

Prakash K Pandalai

http://www.w3.org/2001/XMLSchema#string

R Taylor Ripley

http://www.w3.org/2001/XMLSchema#string

Russell C Langan

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

Cancer statistics, 2010

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411

Balloon catheter hypoxic abdominal perfusion with Mitomycin C and Melphalan for locally advanced pancreatic cancer: a phase I-II trial.

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

Regional chemotherapy for advanced pancreatic carcinoma.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

P304

678-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0B013E318249955A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22695088

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

3375496

http://www.w3.org/2001/XMLSchema#string